KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other financing activities (2017 - 2025)

Historic Other financing activities for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $35.0 million.

  • Elanco Animal Health's Other financing activities rose 53750.0% to $35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 19130.43%. This contributed to the annual value of -$17.0 million for FY2024, which is 18333.33% down from last year.
  • Per Elanco Animal Health's latest filing, its Other financing activities stood at $35.0 million for Q3 2025, which was up 53750.0% from -$20.0 million recorded in Q1 2025.
  • Elanco Animal Health's Other financing activities' 5-year high stood at $35.0 million during Q3 2025, with a 5-year trough of -$20.0 million in Q1 2025.
  • For the 5-year period, Elanco Animal Health's Other financing activities averaged around -$4.7 million, with its median value being -$7.0 million (2023).
  • As far as peak fluctuations go, Elanco Animal Health's Other financing activities plummeted by 130000.0% in 2021, and later soared by 53750.0% in 2025.
  • Elanco Animal Health's Other financing activities (Quarter) stood at -$14.0 million in 2021, then skyrocketed by 107.14% to $1.0 million in 2022, then crashed by 200.0% to -$1.0 million in 2023, then soared by 700.0% to $6.0 million in 2024, then skyrocketed by 483.33% to $35.0 million in 2025.
  • Its last three reported values are $35.0 million in Q3 2025, -$20.0 million for Q1 2025, and $6.0 million during Q4 2024.